Kent E. Lieginger
Direttore/Membro del Consiglio presso University of the Sciences in Philadelphia
Posizioni attive di Kent E. Lieginger
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| University of the Sciences in Philadelphia | Direttore/Membro del Consiglio | 01/01/2013 | - |
Storia della carriera di Kent E. Lieginger
Precedenti posizioni note di Kent E. Lieginger
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2004 | 01/07/2014 |
| The Genentech Foundation | Direttore/Membro del Consiglio | 01/01/2005 | 01/01/2012 |
| University of California | Corporate Officer/Principal | - | - |
| GSK PLC | Corporate Officer/Principal | - | - |
| ACHAOGEN | Direttore/Membro del Consiglio | 13/03/2015 | - |
| Independent Dir/Board Member | 13/03/2015 | - |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| Regno Unito | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
| Miscellaneous | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GSK PLC | Health Technology |
| Aziende private | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
| The Genentech Foundation | Miscellaneous |
- Borsa valori
- Insiders
- Kent E. Lieginger
- Esperienza
